Tool overview
Rhizome AI is listed under Research AI tools.
What is Rhizome AI?
Rhizome AI is a regulatory research agent for life-sciences teams. It searches large public regulatory and clinical datasets, reads up to hundreds or thousands of documents for a question, and returns source-linked answers about FDA, EMA, and other health-authority decisions.
Best for
Life-sciences teams that need fast, traceable regulatory research
Who is it for?
Decision note
Pricing has changed across cached versions. Confirm the live checkout amount and included databases before publishing or purchasing.
Key features
Deep search across regulatory and clinical databases
Answers backed by page-level citations
FDA premarket and postmarket datasets
EMA EPAR, guideline, and CTIS coverage
Health-authority data from additional regions
Business plans with SSO and office hours
Use cases
Researching FDA precedent and feedback
Preparing for regulator meetings
Reviewing inspections, labels, and guidance
Comparing regulatory pathways across regions
Fact-checking life-sciences research with citations
Pros
- Every statement is linked to a source
- Free tier supports real regulatory questions
- Covers major FDA and EMA datasets
- Business tier includes SSO and expert office hours
Cons
- The first paid plan starts at $400 per month
- Regulatory answers still need expert review
- Some global datasets require enterprise access
Limitations
Rhizome supports research and does not replace regulatory counsel, official agency communication, or submission review. Users should inspect the cited documents, confirm current guidance and jurisdiction, and validate every conclusion before clinical, quality, or filing decisions.
Pricing details
Billing options
Pricing note
Free includes 10 messages per month. Project is $400 per month, Professional $4,000 per year, and Business $30,000 per year for five seats. Enterprise is custom. Pricing pages should be rechecked because older cached pages showed different annual amounts.
Supported languages
- English
Please log in to join the discussion.